Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate versus levetiracetam monotherapy in pediatric new-onset epilepsy
2012-001552-19Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in epilepsy comparing Topiramate monotherapy with Levetiracetam monotherapy (2 arms). Primary endpoint: Percentage of subjects with kidney stones. Started Sep 2014; status: completed.
02
Drugs
topiramatelevetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2012-001552-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001552-19.